Docebo Inc. current report, Q3 FY2022

Business Context and Reporting Period

Docebo Inc. filed this Form 6-K in November 2022, reporting on its unaudited condensed consolidated interim financial statements and management’s discussion for the three and nine months ended September 30, 2022. The filing was submitted as a report of a foreign private issuer and includes quarterly financial statements, MD&A, and the company’s November 10, 2022 earnings release.

Financial Results and Key Metrics

The provided filing text identifies the financial statements and related exhibits but does not include their underlying financial data. Accordingly, the filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, or other key financial metrics.

Material Changes Versus the Prior Comparable Period

The provided text does not include the comparative financial results or management’s discussion needed to identify material changes from the prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

The provided text does not include management commentary, guidance, outlook, risk disclosures, contingencies, or unusual items. These matters may be addressed in the incorporated exhibits, particularly Exhibit 99.2 and Exhibit 99.3, but their contents are not included in the source text.

Important Facts to Verify

  • Verify the detailed three- and nine-month financial results in Exhibit 99.1.
  • Verify operating performance, liquidity, cash flow, and risk commentary in Exhibit 99.2.
  • Verify guidance and management’s reported third-quarter results in Exhibit 99.3, dated November 10, 2022.
  • Confirm the filing’s incorporated-by-reference exhibits and their availability in the SEC filing record.